Summary
TrovaGene, Inc. (TrovaGene), formally known as Xenomics, Inc. is a development stage molecular diagnostic company. It develops and commercializes proprietary diagnostic technologies for screening and monitoring of various diseases. The company’s proprietary urine-based molecular diagnostic tests are used in detection of transrenal DNA (TrDNA) and RNA (TrRNA). The technology can be used in tumor detection and monitoring, prenatal genetic testing, infectious diseases, tissue transplantation, forensic identification, and for patient selection in clinical trials. It out-licenses its transrenal technologies to extend oncogene mutation detection using urine as a sample. The company also holds worldwide rights to worldwide rights to nucleophosmin-1 (NPM1), an informative biomarker for acute myelogenous leukemia (AML) and mutations in the SF3B1 gene. TrovaGene is headquartered in California, the US.
TrovaGene, Inc. (TROV) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Global Medical Equipment And Supply Industry
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
TrovaGene, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013 5
TrovaGene, Inc., Medical Equipment Deals By Type, 2007 to YTD 2013 6
TrovaGene, Inc., Medical Equipment, Deals By Region, 2007 to YTD 2013 7
TrovaGene, Inc., Medical Equipment, Deals By Market, 2007 to YTD 2013 8
TrovaGene, Inc., Medical Equipment, Deals Summary, 2007 to YTD 2013 9
TrovaGene, Inc., Medical Equipment, Deal Details 10
Asset Purchase 10
TrovaGene Completes Acquisition Of CLIA-Certified Lab From MultiGEN Diagnostics 10
Venture Financing 12
TrovaGene Raises US$6.6 Million In Venture Financing 12
Partnerships 13
Trovagene Enters Into Licensing Agreement With Strand Life Sciences For HPV Test 13
TrovaGene Enters Into Licensing Agreement With Brunangelo Falini 14
TrovaGene Enters Into An Agreement With Skyline Diagnostics 15
TrovaGene Enters Into Licensing Agreement With Lab Corporation of America Holdings And InVivoScribe Technologies 16
Xenomics Signs An Agreement With SEQUENOM 17
Warnex Enters Into Licensing Agreement With Xenomics 18
Xenomics Signs An Agreement With Asuragen 19
Xenomics Signs Licensing Agreement With IPSOGEN 20
TrovaGene Enters Into R&D Agreement With PerkinElmer Health Sciences 21
TrovaGene Enters Into Licensing Agreement With Amedeo Avogadro University And Sapienza University 23
Equity Offering 24
Trovagene Files Shelf Registration Statement For Public Offering Of Securities For US$150 Million 24
Trovagene Completes Private Placement Of Units For US$4 Million 26
Trovagene Completes Exercise Of Underwriters' Option For Public Offering Of Units For US$10.6 Million 27
TrovaGene, Inc. - Key Competitors 29
Key Employees 30
Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 32
Strategy And Business Planning 32
Jan 03, 2013: Trovagene Announces Clinical Collaboration With University of Texas MD Anderson Cancer Center To Detect Transrenal BRAF Mutations In Primary And Metastatic Cancers 32
Feb 27, 2012: Trovagene Partners With Leomics To Expand Business Development Activities 32
Financial Announcements 32
Apr 01, 2013: Trovagene Reports 2012 Results 32
Nov 14, 2012: Trovagene Reports Q3 2012 Results 33
Aug 15, 2012: Trovagene Reports Q2 2012 Results 34
May 15, 2012: Trovagene Reports Q1 2012 Results 34
Mar 30, 2012: Trovagene Reports 2011 Results 35
Research And Development 35
Jun 13, 2012: Trovagene To Study Trans Renal KRAS Mutation Detection In Pancreatic Cancer 35
Corporate Communications 36
Mar 04, 2013: Trovagene Appoints Mark Erlander As CSO 36
Feb 14, 2012: Trovagene Appoints Charlie Rodi As CTO 36
Feb 10, 2012: Trovagene Appoints Stephen Zaniboni As CFO 37
Product News 37
Mar 27, 2013: Trovagene Launches Urine-Based HPV Test 37
Nov 28, 2012: Trovagene To Introduce Transrenal KRAS Test For Transrenal Cancer Mutation Monitoring 37
Nov 27, 2012: Trovagene And Barretos Cancer Hospital, Brazil, To Evaluate Urine-Based HPV Assay As Potential Pap Smear Replacement 38
May 02, 2012: Trovagene Announces Plans To Develop New Test For High Risk HPV Carrier Screening From Urine 38
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40
List of Tables
TrovaGene, Inc., Medical Equipment, Key Facts, 2012 1
TrovaGene, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013 1
TrovaGene, Inc., Medical Equipment, Deals By Region, 2007 to YTD 2013 1
TrovaGene, Inc., Medical Equipment, Deals By Market, 2007 to YTD 2013 1
TrovaGene, Inc., Medical Equipment, Deals Summary, 2007 to YTD 2013 1
TrovaGene, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013 5
TrovaGene, Inc., Medical Equipment Deals By Type, 2007 to YTD 2013 6
TrovaGene, Inc., Medical Equipment, Deals By Region, 2007 to YTD 2013 7
TrovaGene, Inc., Deals By Market, 2007 to YTD 2013 8
TrovaGene, Inc., Medical Equipment, Deals Summary, 2007 to YTD 2013 9
TrovaGene Completes Acquisition Of CLIA-Certified Lab From MultiGEN Diagnostics 10
TrovaGene Raises US$6.6 Million In Venture Financing 12
Trovagene Enters Into Licensing Agreement With Strand Life Sciences For HPV Test 13
TrovaGene Enters Into Licensing Agreement With Brunangelo Falini 14
TrovaGene Enters Into An Agreement With Skyline Diagnostics 15
TrovaGene Enters Into Licensing Agreement With Lab Corporation of America Holdings And InVivoScribe Technologies 16
Xenomics Signs An Agreement With SEQUENOM 17
Warnex Enters Into Licensing Agreement With Xenomics 18
Xenomics Signs An Agreement With Asuragen 19
Xenomics Signs Licensing Agreement With IPSOGEN 20
TrovaGene Enters Into R&D Agreement With PerkinElmer Health Sciences 21
TrovaGene Enters Into Licensing Agreement With Amedeo Avogadro University And Sapienza University 23
Trovagene Files Shelf Registration Statement For Public Offering Of Securities For US$150 Million 24
Trovagene Completes Private Placement Of Units For US$4 Million 26
Trovagene Completes Exercise Of Underwriters' Option For Public Offering Of Units For US$10.6 Million 27
TrovaGene, Inc., Key Competitors 29
TrovaGene, Inc., Key Employees 30
TrovaGene, Inc., Other Locations 31
List of Figures
TrovaGene, Inc., Medical Equipment, Deals by Type, 2007 to YTD 2013 1
TrovaGene, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013 5
TrovaGene, Inc., Medical Equipment, Deals by Type, 2007 to YTD 2013 6
TrovaGene, Inc., Medical Equipment, Deals By Region, 2007 to YTD 2013 7
TrovaGene, Inc., Medical Equipment, Deals by Market, 2007 to YTD 2013 8
